FDA looks at obesity devices for children
This article was originally published in Clinica
Executive Summary
The FDA's paediatric advisory committee, long focused on drug matters, turns to a timely device topic next month - paediatric obesity, clinical trial designs for devices intended to treat obesity in children and related ethical issues. With as many as 15% of children and adolescents (aged 6-19) obese or overweight, and obesity in adolescents rapidly becoming a national epidemic, manufacturers are interested in devices that can treat the problem.